Aaron Michels
Director, Clinical Immunology, Barbara Davis Center for Diabetes · University of Colorado School of Medicine
Credentials: · · · · ·
History
PresentClinical Immunology · University of Colorado School of Medicine
- 2004–2007
Internal Medicine
Research
Review · The Lancet · 2014 · Last of 3 authors · 1,806 citations
The Journal of Clinical Endocrinology & Metabolism · 2013 · 271 citations
Islet-Derived CD4 T Cells Targeting Proinsulin in Human Autoimmune Diabetes
Diabetes · 2017 · First of 14 authors · 173 citations
21 papers
- KS
16 papers · 6 as a resident
12 papers · 7 as a fellow
12 papers
10 papers
- GE
9 papers
8 papers
4 papers
Grants
- 2013–2030
Islet-Specific CD8 T Cells in the Pathogenesis of Type 1 Diabetes
National Institute of Diabetes and Digestive and Kidney Diseases · R01
PI · $3.6M · University of Colorado Denver
- 2017–2027
Insulin Specific T Cell Response Shaped by Diabetes Protective MHC Class II Molecules
National Institute of Diabetes and Digestive and Kidney Diseases · R01
Contact PI · $3.6M · University of Colorado Denver
- 1982–2027
Multiple Autoantigens, Multiple Epitopes of Type 1 Diabetes
National Institute of Diabetes and Digestive and Kidney Diseases · R01
Contact PI · $1.9M · University of Colorado Denver
- 2016–2020
Insulin Specific T and B Cells in Type 1 Diabetes
National Institute of Diabetes and Digestive and Kidney Diseases · DP3
Contact PI · $1.7M · University of Colorado Denver
Clinical trials
- 2013–2016
Effect of Methyldopa on MHC Class II Antigen Presentation in Type 1 Diabetes
Principal investigator · Completed
University of Colorado, Denver